Healthcare - Biotechnology - NASDAQ - US
$ 3.19
0.315 %
$ 130 M
Market Cap
-1.54
P/E
Price Target
Average
244.83%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
22.91%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Vigil Neuroscience, Inc.
Wall Street analysts predict an average 1-year price target for VIGL of $11 , with forecasts ranging from a low of $11 to a high of $11 .
VIGL Lowest Price Target
Wall Street Target
11 USD
244.83%
VIGL Average Price Target
Wall Street Target
11 USD
244.83%
VIGL Highest Price Target
Wall Street Target
11 USD
244.83%
REVENUE FORECAST
Revenue Forecast Chart VIGL
EBIT FORECAST
EBIT Forecast Chart VIGL
NET INCOME FORECAST
Net Income Chart VIGL